FDA Inspection
BMC 1092, Inc.BMC 1092, Inc. – FDA Inspection, Nov 10, 2021
Record Details
This FDA Inspection record concerns BMC 1092, Inc., with an inspection on November 10, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- BMC 1092, Inc.
- Inspection Date
- November 10, 2021
- Product Type
- Drugs
View Company Profile
ID · 31bc65c8-80c0-4289-b494-a4e67e0fbffb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1156461
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BMC 1092, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2024 | Not classified | Chicago District Office | |
| September 28, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BMC 1092, Inc.
- FDA Inspection 1238030 - 2024-05-15
- FDA Inspection 988284 - 2016-09-28
- FDA Inspection 866885 - 2014-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.